Key result
Targeting epicardial adipose tissue shows promise for improving outcomes after catheter ablation for AF.
Highlights epicardial adipose tissue as a key metabolic target to lower arrhythmia recurrence after catheter ablation, suggesting novel therapeutic avenues for atrial fibrillation management.
Atrial fibrillation (AF) remains a major global health challenge, with high recurrence rates after catheter ablation despite advances in proc...
No takes yet. Share an insight, caveat, or question.
Zwolińska et al. (2026) studied this question. Epicardial adipose tissue represents a promising metabolic target for improving clinical outcomes following catheter ablation for atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: